Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date

About this update from Sharp Therapeutics Corp.

Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting DateShareholders Must Recast Their Votes to be CountedPittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - June 30, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that its annual meeting of shareholders will be held at 10:00 a.m. (Toronto time) on July 21, 2026 (the "Meeting"), having been postponed from the initial meeting date of June 30, 2026.The Company has filed an amended and restated notice of meeting (the "Amended and Restated NOM") and an amended and restated management information circular for the Meeting (the "Amended and Restated Circular") in order to give notice and disclosure in respect of the re-approval of the Company's stock option plan (the "Stock Option Plan"), which will be a matter of business considered at the Meeting.The ordinary resolution re-approving the Stock Option Plan (the "Plan Resolution") was not included in the original management information circular dated May 27, 2026 or in the form of proxy or voting instruction form previously sent by the Company in connection with the Meeting. The Amended and Restated Circular includes the necessary information with respect to the Plan Resolution and the Stock Option Plan.Shareholders should disregard the form of proxy or voting instruction form that was delivered to them with the prior notice of meeting and management information circular. A new form of proxy and voting instruction form will be provided to shareholders together with the Amended and Restated NOM and the Amended and Restated Circular.For shareholders that have already provided voting instructions using their initial form of proxy, voting instruction form or control number, those instructions are no longer valid. Shareholders must provide new voting instructions for their shares to be voted, and should refer to the Amended and Restated Circular and new form of proxy or voting instruction form. Proxies must be received by 10:00 a.m. (Toronto time) on July 17, 2026, or not less than forty-eight (48) hours (excluding Saturdays, Sundays and holidays) before the time any adjourned Meeting is reconvened, or any postponed Meeting is convened. Copies of the Amended and Restated NOM, the Amended and Restated Circular, the new form of proxy and the new ...

View stock analysis, news, and events for Sharp Therapeutics Corp.